Impact Factor 2019: 1.940 (@Clarivate Analytics)
5-Year Impact Factor: 1.955 (@Clarivate Analytics)
  • Users Online: 33
  • Print this page
  • Email this page

    Article Cited by others

LETTER TO EDITOR

Dose prediction of lopinavir/ritonavir for 2019-novel coronavirus (2019-nCoV) infection based on mathematic modeling

Yasri Sora, Wiwanitkit Viroj

Year : 2020| Volume: 13| Issue : 3 | Page no: 137-138

   This article has been cited by
 
1 Evidence of Protective Effect of Hydroxychloroquine on COVID-19
Beuy Joob,Viroj Wiwanitkit
The Journal of Rheumatology. 2020; 47(10): 1587.1
[Pubmed]  [Google Scholar] [DOI]
2 SARS-CoV-2 and HIV
Beuy Joob,Viroj Wiwanitkit
Journal of Medical Virology. 2020;
[Pubmed]  [Google Scholar] [DOI]
3 COVID-19 and comorbidities: Deleterious impact on infected patients
Hasan Ejaz,Abdullah Alsrhani,Aizza Zafar,Humera Javed,Kashaf Junaid,Abualgasim E. Abdalla,Khalid O.A. Abosalif,Zeeshan Ahmed,Sonia Younas
Journal of Infection and Public Health. 2020;
[Pubmed]  [Google Scholar] [DOI]
4 Pharmacological treatments of COVID-19
Adeleh Sahebnasagh,Razieh Avan,Fatemeh Saghafi,Mojataba Mojtahedzadeh,Afsaneh Sadremomtaz,Omid Arasteh,Asal Tanzifi,Fatemeh Faramarzi,Reza Negarandeh,Mohammadreza Safdari,Masoud Khataminia,Hassan Rezai Ghaleno,Solomon Habtemariam,Amirhosein Khoshi
Pharmacological Reports. 2020;
[Pubmed]  [Google Scholar] [DOI]
5

COVID-19-Related Knowledge, Attitude and Practice Among Hospital and Community Pharmacists in Addis Ababa, Ethiopia

Zelalem Tilahun Tesfaye,Malede Berihun Yismaw,Zenebe Negash,Akeberegn Gorems Ayele
Integrated Pharmacy Research and Practice. 2020; Volume 9: 105
[Pubmed]  [Google Scholar] [DOI]

 

Read this article